KMT6 / EZH2 Antibody

Product no.: EZH2-201AP
$285.00


General Information

 

 

Product

 

KMT6 / EZH2 Antibody

Description

Affinity Purified Histone-lysine N-methyltransferase EZH2 Antibody

Verified Applications

ELISA, IHC, IP, WB

Host

Rabbit

Species Cross Reactivity

Human, Mouse, Rat

Immunogen

Synthetic peptide taken within amino acid region 60-110 on human Histone-lysine N-methyltransferase EZH protein.


Physical Properties

 

 

Quantity

 

100 µg

Volume

200 µl

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Form

Affinity Purified

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20C for long term storage


Application Protocol

 

ELISA

 

1:50,000

Immunohistochemistry 1:50-1:200

Immunoprecipitation

1:200

Western Blot

1:2,500-1:5,000


Protein

 

Uniprot #

 

A0A090N8E9

Molecular Function

chromatin DNA binding

histone-lysine N-methyltransferase activity

primary miRNA binding

ribonucleoprotein complex binding

RNA polymerase II core promoter sequence-specific DNA binding

RNA polymerase II proximal promoter sequence-specific DNA binding

Subcellular Location

Nucleus, Cytoplasm

Alternative Nomenclature

Enhancer of zeste 2 antibody

enhancer of zeste 2 polycomb repressive complex 2 subunit antibody

ENX 1 antibody

Enx1h antibody

EZH 2 antibody

EZH1 antibody

EZH2b antibody

Histone-lysine N-methyltransferase EZH2 antibody

KMT 6 antibody

KMT6A antibody

Lysine N-methyltransferase 6 antibody

WVS antibody

WVS2 antibody

   

Protein information supplied by UniProt.

 

Accessories

Product Note Status Price
KMT6 / EZH2 Antibody BIOTIN KMT6 / EZH2 Antibody BIOTIN
EZH2-BIOTIN $375.00 *
KMT6 / EZH2 Antibody FITC KMT6 / EZH2 Antibody FITC
EZH2-FITC $375.00 *
KMT6 / EZH2 Blocking Peptide KMT6 / EZH2 Blocking Peptide
P-EZH2 $155.00 *
KMT6 / EZH2 Positive Control KMT6 / EZH2 Positive Control
PC-EZH2 $200.00 *
Display accessory details

Browse these categories as well: Methylation, Chromatin Modifying Enzymes, Lysine methylation, Tumor Biomarkers, Primaries